ABVC BIOPHARMA, INC. — Form 8-K
Filed July 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
ABVC BioPharma changed auditors effective July 1, 2026. S&E (the prior auditor, located in Rowland Heights, California) confirmed the change in a letter to the SEC. The filing does not disclose the name of the new auditor, reason for the change, or any audit disagreements or reportable events.
Why this rating
Auditor changes are routine corporate housekeeping absent disclosed disputes. No disagreement or reportable event mentioned. Neutral for small-cap company.
Extracted items
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.